The treatment of established intracranial tumors by in situ retroviral IFN-γ transfer

This publication has 34 references indexed in Scilit:

• Experimental gene therapy against subcutaneously implanted glioma with a herpes simplex virus-defective vector expressing interferon-γ
  Cancer Gene Therapy, 1999
• Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-γ, interleukin-7, or B7-1-transfected tumor cells
  Cancer Gene Therapy, 1999
• Generation of a Systemic Antitumor Response with Regional Intratumoral Injections of InterferonγRetroviral Vector
  Human Gene Therapy, 1998
• The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-γand Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells
  Human Gene Therapy, 1998
• A Retroviral Vector That Allows Efficient Co-Expression of Two Genes and the Versatility of Alternate Selection Markers
  Human Gene Therapy, 1997
• The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
  Journal of Biological Chemistry, 1995
• Retroviral Gene Transfer Using Safe and Efficient Packaging Cell Lines
  Annals of the New York Academy of Sciences, 1990
• Role of interleukin 2, interleukin 4, and alpha, beta, and gamma interferon in stimulating macrophage antibody-dependent tumoricidal activity.
  The Journal of Experimental Medicine, 1988
• In vitro antigenic modulation of human neuroblastoma cells induced by ifn‐γ, retinoic acid and dibutyryl cyclic amp
  International Journal of Cancer, 1987
• Recombinant interferon-γ can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens
  European Journal of Immunology, 1985